Cargando…
A protocol for the development of core outcome sets for effectiveness trials and clinical audits in renal cell cancer (R‐COS)
BACKGROUND: There is inconsistency in outcomes collected in renal cell cancer (RCC) intervention effectiveness studies and variability in their definitions. This makes critical summaries of the evidence base difficult and sub‐optimally informative for clinical practice guidelines and decision‐making...
Autores principales: | MacLennan, Steven, Wintner, Lisa M., Beyer, Katharina, Lawlor, Ailbhe, Tripathee, Sheela, Dabestani, Saeed, Marconi, Lorenzo, Giles, Rachel H., Woodward, Rose, Van Hemelrijck, Mieke, Bex, Axel, Zondervan, Patricia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10447209/ https://www.ncbi.nlm.nih.gov/pubmed/37636213 http://dx.doi.org/10.1002/bco2.266 |
Ejemplares similares
-
A Systematic Review of Heterogeneity in Outcome Definition and Reporting in Localised Renal Cancer
por: Beyer, Katharina, et al.
Publicado: (2022) -
“Vicarious thinking” was a key driver of score change in Delphi surveys for COS development and is facilitated by feedback of results
por: Fish, Rebecca, et al.
Publicado: (2020) -
Core Outcome Set–STAndards for Reporting: The COS-STAR Statement
por: Kirkham, Jamie J., et al.
Publicado: (2016) -
Core Outcome Set-STAndards for Development: The COS-STAD recommendations
por: Kirkham, Jamie J., et al.
Publicado: (2017) -
Core Outcome Set-STAndardised Protocol Items: the COS-STAP Statement
por: Kirkham, Jamie J., et al.
Publicado: (2019)